Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-16 Sale |
2023-06-21 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,655 | $14.4 | $23,835 | 378,613 (Indirect Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:04 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,370 | $15.1 | $20,686 | 446,168 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:06 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
2,403 | $21.24 | $51,043 | 365,150 (Indirect Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:34 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,768 | $10.75 | $19,006 | 367,553 (Indirect Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:01 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,366 | $9.05 | $12,362 | 369,321 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
508 | $48.87 | $24,826 | 388,987 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-15 Option Award |
2023-02-17 4:04 pm |
N/A 2033-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
82,388 | $0 | 446,168 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
102,500 | $0 | 452,687 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:00 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
93,365 | $0 | 432,452 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 7:00 pm |
N/A 2031-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
61,000 | $0 | 388,987 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
9,029 | $0 | 328,495 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
9,029 | $1.89 | 328,495 (Direct) |
View |
| 2020-07-22 Exercise |
2020-07-24 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
130,000 | $0 | 328,495 (Direct) |
View |
| 2020-07-22 Exercise |
2020-07-24 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
130,000 | $1.89 | 328,495 (Direct) |
View |